Navigation Links
ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
Date:10/14/2009

MILWAUKEE, Oct. 14 /PRNewswire/ -- ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.

Jonathan LeBowitz, Chief Scientific Officer of ZyStor Therapeutics, Inc., said, "We are pleased and very proud to announce that ZC-701 has been cleared by the FDA for a Phase I human safety trial. A small and dedicated team has brought ZC-701 from concept to the clinic and now ZyStor is poised to bring this promising treatment to Pompe patients. We hope that these patients will benefit from the improved targeting of ZC-701 to the tissues in the body that are most affected by Pompe disease."

Pompe disease is one of a group of about 50 rare genetic disorders called Lysosomal Storage Diseases (LSDs) that interfere with the body's ability to degrade complex molecules within the lysosome. Pompe disease affects 5,000-10,000 people worldwide, making it one of the most prevalent LSDs. It is caused by an inherited deficiency in a lysosomal enzyme, acid-alpha-glucosidase (GAA). Deficiency of GAA results in lysosomal glycogen accumulation in multiple tissues, with cardiac and skeletal muscle tissues most seriously affected. The most severe form of Pompe disease is the infantile-onset form in which patients have critical cardiomyopathy and heart failure, severe muscle hypotonia and die prior to 2 years of age.

ZyStor's Glycosylation Independent Lysosomal Targeting (GILT) technology is the first peptide-based targeting technology that enables efficient targeting of enzyme replacement therapeutics to the lysosomal compartment of c
'/>"/>

SOURCE ZyStor Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
2. Solace Therapeutics, Inc. Announces CE Mark Approval
3. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
4. Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
5. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
6. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
7. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
8. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
9. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
10. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
11. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... MOUNTAIN VIEW, Calif., April 30, 2015 Omnicell, Inc. ... and supply management solutions to healthcare systems, today announced ... GAAP results: Revenue for the first quarter ... 14.2% from the first quarter of 2014, and down ... 2014. First quarter 2015 net income as ...
(Date:4/30/2015)... VIEW, Calif. , April 30, 2015  IRIDEX ... will release its first quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
(Date:4/30/2015)... PLEASANTON, Calif. , April 30, 2015  Thoratec ... mechanical circulatory support therapies to save, support and restore ... Bank of America Merrill Lynch 2015 Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight time (1:40 p.m., Eastern Daylight Time). ...
Breaking Medicine Technology:Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2
... The Pharmaceutical Research and Manufacturers of America (PhRMA) today ... Board of Directors. "We are pleased to ... of Directors," said PhRMA President and Chief Executive Officer ... most research-intensive sectors in the U.S., they bring to ...
... Spectros white LED patent was validated during reexamination by the ... In a reexamination of U.S. Patent No. 6,711,426, the ... in medical spectroscopy is unique and protectable, and that certain ... under this Spectros patent. "This is a broad ...
Cached Medicine Technology:PhRMA Elects Four New Members to Board of Directors 2PhRMA Elects Four New Members to Board of Directors 3Spectros White LED Patent Scope Affirmed In U.S. Patent Office Reexamination 2
(Date:5/3/2015)... May 03, 2015 NuevaCare announced today ... two upcoming area seminars. The first event will take ... Regional Stroke Conference to be held at The Magnolia ... Wednesday, May 13 during the Dementia Conference to be ... “These seminars offer an excellent opportunity to learn about ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company that ... the , May 5 - 7, 2015 Minnesota Safety ... the conference include its bestselling TaskMate sit stand solutions. ... 6100 TaskMate Executive. Features of the 6100 TaskMate Executive ... extended platform work surface and supply holders. Weighing 50 ...
(Date:5/2/2015)... May 02, 2015 Vancouver fencing company, QS ... provide valuable advice to prospective clients related to their questions ... to install railings around their decks and patios. While that ... that pop up once the person rolls up their sleeve ... installing a railing in finding a gate that matches it. ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 It’s a ... deadly natural disaster strikes anywhere on this planet, cyber ... human sympathy and compassion for their own personal gain. ... Computer Emergency Readiness Team) issued an alert titled ... potential email scams citing the earthquake in Nepal. The ...
(Date:5/2/2015)... Ohio (PRWEB) May 02, 2015 On ... Liverpool City Hospital (ELCH) gathered to celebrate improvements in ... River Valley Health Partners (RVHP), had zero acquired ventilator ... urinary catheter associated infections. ELCH was also recently named ... The management team at ELCH credited the teamwork of ...
Breaking Medicine News(10 mins):Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... lower risk of ischemic heart disease or stroke. They remain ... to consume more alcohol., ,This research was reported in ... Health., ,Researchers for the study had said that milk ... of its association with cholesterol levels. However people should not ...
... out that sex differences in sleep patterns do exist, with ... carried out a national survey of 39,588 people of the ... of Taiwan. The researchers considered several factors other than gender ... ,The results of the study had shown that there is ...
... reported that in manning the progress of osteoarthritis// of the ... hip involves joint space narrowing that is accompanied by severe ... lead to total hip replacement operation in patients who may ... process of disease progression. ,The researchers had studied ...
... coughs for months or even// years have a high possibility ... the researchers of Montefiore Cough Center, US, have reported that ... average of nine years, 53% of them were also suffering ... Thoracic Society International Conference 2005. ,The researchers did a ...
... scientists have reported that delaying pregnancy may result in ... and more women deciding to put off pregnancy for ... pregnancy for women across the globe. Delaying in getting ... abnormal number of chromosomes, and other conditions. This is ...
... The Lancet that for identifying the risk of breast cancer ... their families, MRI scanning does score more than mammography. ... breast cancer are predisposed to the disease genetically. These women ... adulthood. Screening young women for this purpose is done more ...
Cached Medicine News:
... great versatility in epilation and the ... compactness and easy-transportability of the system. ... developed for Smartepil II plus, and ... for hair removal of tricky areas ...
... new and efficient method applied to dermatological ... ongoing research and development with hundreds of ... light source, but rather a platform for ... horizons in pulsed-light-based technology, the most valid ...
Auto Refkeratomoeter...
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
Medicine Products: